1. A First‐in‐Human Clinical Study With TRV734, an Orally Bioavailable G‐Protein–Biased Ligand at the μ‐Opioid Receptor. Issue 2 (8th July 2019) Authors: James, Ian E.; Skobieranda, Franck; Soergel, David G.; Ramos, Kimberly A.; Ruff, Dennis; Fossler, Michael J. Journal: Clinical pharmacology in drug development Issue: Volume 9:Issue 2(2020) Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I randomized, double‐blind, single subcutaneous dose escalation study to determine the safety, tolerability, and pharmacokinetics of rezafungin in healthy adult subjects. Issue 7 (4th May 2022) Authors: Gu, Kenan; Ruff, Dennis; Key, Cassandra; Thompson, Marissa; Jiang, Shoshanna; Sandison, Taylor; Flanagan, Shawn Journal: Clinical and translational science Issue: Volume 15:Issue 7(2022) Page Start: 1592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Randomized, Placebo‐Controlled, Multiple‐Ascending‐Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Soluble Guanylate Cyclase Stimulator Praliciguat in Healthy Subjects. Issue 5 (13th November 2018) Authors: Hanrahan, John P.; Wakefield, James D.; Wilson, Phebe J.; Mihova, Marina; Chickering, Jennifer G.; Ruff, Dennis; Hall, Michael; Milne, G. Todd; Currie, Mark G.; Profy, Albert T. Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 5(2019) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Absence of an effect of T89 on the steady‐state pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers. (16th November 2013) Authors: Wang, Ping; Sun, He; Yang, Liu; Li, Ling‐Yan; Hao, Jing; Ruff, Dennis; Guo, Zhi‐Xin Journal: Journal of clinical pharmacology Issue: Volume 54:Number 2(2014:Feb.) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Two‐Part Phase 1 Multiple‐Ascending‐Dose Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of TRV734 in Healthy Adults. Issue 1 (3rd September 2021) Authors: Ramos, Kimberly A.; James, Ian E.; Skobieranda, Franck; Soergel, David G.; Ruff, Dennis; Fossler, Michael J. Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 1(2022) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗